Corrigendum: Nonautophagic cytoplasmic vacuolation death induction in human PC-3M prostate cancer by curcumin through reactive oxygen species-mediated endoplasmic reticulum stress (Scientific Reports (2015) 5 (10420) DOI: 10.1038/srep10420);Nonautophagic cytoplasmic vacuolation death induction in human PC-3M prostate cancer by curcumin through reactive oxygen species -mediated endoplasmic reticulum stress

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Lee, Wei Jiunn ^a   Chien, Ming Hsien ^a,b   Chow, Jyh Ming ^a   Chang, Junn Liang ^c,d   Wen, Yu Ching ^a,b   Lin, Yung Wei ^a,b   Cheng, Chao Wen ^b   Lai, Gi Ming ^e   Hsiao, Michael ^f   Lee, Liang Ming ^a  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c TAOYUAN ARMED FORCES GENERAL HOSPITAL   (Taiwan)

^d MING CHUAN UNIVERSITY   (Taiwan)

^e TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^f GENOMICS RESEARCH CENTER   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; CURCUMIN; CYCLOHEXIMIDE; DDIT3 PROTEIN, HUMAN; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 153; HEAT SHOCK PROTEIN; MAP1LC3A PROTEIN, HUMAN; MICROTUBULE ASSOCIATED PROTEIN; MOLECULAR CHAPERONE GRP78; REACTIVE OXYGEN METABOLITE; SMALL INTERFERING RNA;

ANIMAL; ANTAGONISTS AND INHIBITORS; APOPTOSIS; CELL SURVIVAL; CELL VACUOLE; DISEASE MODEL; DRUG EFFECTS; ENDOPLASMIC RETICULUM STRESS; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; MOUSE; PATHOLOGY; PROSTATE TUMOR; RNA INTERFERENCE; SCID MOUSE; TUMOR CELL LINE; XENOGRAFT;

ACETYLCYSTEINE; ANIMALS; APOPTOSIS; CELL LINE, TUMOR; CELL SURVIVAL; CURCUMIN; CYCLOHEXIMIDE; DISEASE MODELS, ANIMAL; ENDOPLASMIC RETICULUM STRESS; HEAT-SHOCK PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, SCID; MICROTUBULE-ASSOCIATED PROTEINS; PROSTATIC NEOPLASMS; REACTIVE OXYGEN SPECIES; RNA INTERFERENCE; RNA, SMALL INTERFERING; TRANSCRIPTION FACTOR CHOP; TRANSPLANTATION, HETEROLOGOUS; VACUOLES;

EID: 84934873874     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep42453     Document Type: Erratum

References (42)

1. Jemal, A. et al. Global cancer statistics. CA. Cancer J. Clin. 61, 69-90 (2011).
2. Zelefsky, M. J. et al. Metastasis after radical prostatectomy or external beam radiotherapy for patients with clinically localized prostate cancer: a comparison of clinical cohorts adjusted for case mix. J. Clin. Oncol. 28, 1508-1513 (2010).
3. Harris, W. P., Mostaghel, E. A., Nelson, P. S. & Montgomery, B. Androgen deprivation therapy: progress in understanding mechanisms of resistance and optimizing androgen depletion. Nat. Clin. Pract. Urol. 6, 76-85 (2009).
4. Chen, C. D. et al. Molecular determinants of resistance to antiandrogen therapy. Nat. Med. 10, 33-39 (2004).
5. McKenzie, S. & Kyprianou, N. Apoptosis evasion: the role of survival pathways in prostate cancer progression and therapeutic resistance. J. Cell Biochem. 97, 18-32 (2006).
6. Farrow, J. M., Yang, J. C. & Evans, C. P. Autophagy as a modulator and target in prostate cancer. Nat. Rev. Urol. 11, 508-516 (2014).
7. Zhang, G. et al. Dehydroabietic acid derivative QC2 induces oncosis in hepatocellular carcinoma cells. Biomed. Res. Int. 2014, 682197 (2014).
8. Karl, I. et al. TRAF2 inhibits TRAIL-and CD95L-induced apoptosis and necroptosis. Cell Death Dis. 5, e1444 (2014).
9. Overholtzer, M. et al. A nonapoptotic cell death process, entosis, that occurs by cell-in-cell invasion. Cell. 131, 966-979 (2007).
10. Wen, S., Niu, Y., Lee, S. O. & Chang, C. Androgen receptor (AR) positive vs negative roles in prostate cancer cell deaths including apoptosis, anoikis, entosis, necrosis and autophagic cell death. Cancer Treat. Rev. 40, 31-40 (2014).
11. Zhang, L. Y., Wu, Y. L., Gao, X. H. & Guo, F. Mitochondrial protein cyclophilin-D-mediated programmed necrosis attributes to berberine-induced cytotoxicity in cultured prostate cancer cells. Biochem. Biophys. Res. Commun. 450, 697-703 (2014).
12. Wasik, A. M. et al. WIN55,212-2 induces cytoplasmic vacuolation in apoptosis-resistant MCL cells. Cell Death Dis. 2, e225 (2011).
13. Singha, P. K., Pandeswara, S., Venkatachalam, M. A. & Saikumar, P. Manumycin A inhibits triple-negative breast cancer growth through LC3-mediated cytoplasmic vacuolation death. Cell Death Dis. 4, e457 (2013).
14. Kozlowski, J. M. et al. Metastatic behavior of human tumor cell lines grown in the nude mouse. Cancer Res. 44, 3522-3529 (1984).
15. Kar, R., Singha, P. K., Venkatachalam, M. A. & Saikumar, P. A novel role for MAP1 LC3 in nonautophagic cytoplasmic vacuolation death of cancer cells. Oncogene. 28, 2556-2568 (2009).
16. Sperandio, S., de, Belle. I. & Bredesen, D. E. An alternative, nonapoptotic form of programmed cell death. Proc. Natl. Acad. Sci. U S A. 97, 14376-14381 (2000).
17. Yoon, M. J. et al. Superoxide anion and proteasomal dysfunction contribute to curcumin-induced paraptosis of malignant breast cancer cells. Free. Radic. Biol. Med. 48, 713-726 (2010).
18. Ellgaard, L. & Helenius, A. ER quality control: towards an understanding at the molecular level. Curr. Opin. Cell Biol. 13, 431-437 (2001).
19. Ron, D. Hyperhomocysteinemia and function of the endoplasmic reticulum. J. Clin. Invest. 107, 1221-1222 (2001).
20. Liu, H. et al. Endoplasmic reticulum chaperones GRP78 and calreticulin prevent oxidative stress, Ca2+ disturbances, and cell death in renal epithelial cells. J. Biol. Chem. 272, 21751-21759 (1997).
21. Lao, C. D. et al. Dose escalation of a curcuminoid formulation. BMC Complement Altern. Med. 6, 10 (2006).
22. Aggarwal, B. B., Kumar, A. & Bharti, A. C. Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res. 23, 363-398 (2003).
23. Elmore, S. Apoptosis: a review of programmed cell death. Toxicol. Pathol. 35, 495-516 (2007).
24. Chang, P. C. et al. Autophagy pathway is required for IL-6 induced neuroendocrine differentiation and chemoresistance of prostate cancer LNCaP cells. PLoS One. 9, e88556 (2014).
25. Chen, X. L. et al. Activation of Nrf2/ARE pathway protects endothelial cells from oxidant injury and inhibits inflammatory gene expression. Am. J. Physiol. Heart. Circ. Physiol. 290, H1862-1870 (2006).
26. Walia, G., Pienta, K. J., Simons, J. W. & Soule, H. R. The 19th annual Prostate Cancer Foundation scientific retreat. Cancer Res. 73, 4988-4991 (2013).
27. Ganju, A. et al. Nanoways to overcome docetaxel resistance in prostate cancer. Drug Resist. Updat. 17, 13-23 (2014).
28. Chen, X. et al. Constitutively active Akt is an important regulator of TRAIL sensitivity in prostate cancer. Oncogene. 20, 6073-83 (2001).
29. Chang, L. et al. PI3K/Akt/mTOR pathway inhibitors enhance radiosensitivity in radioresistant prostate cancer cells through inducing apoptosis, reducing autophagy, suppressing NHEJ and HR repair pathways. Cell Death Dis. 5, e1437 (2014).
30. Beevers, C. S., Li, F., Liu, L. & Huang, S. Curcumin inhibits the mammalian target of rapamycin-mediated signaling pathways in cancer cells. Int. J. Cancer. 119, 757-764 (2006).
31. Aoki, H. et al. Evidence that curcumin suppresses the growth of malignant gliomas in vitro and in vivo through induction of autophagy: role of Akt and extracellular signal-regulated kinase signaling pathways. Mol. Pharmacol. 72, 29-39 (2007).
32. Deeb, D. et al. Curcumin[1,7-bis(4-hydroxy-3-methoxyphenyl)-1-6-heptadine-3,5-dione; C21H20O6] sensitizes human prostate cancer cells to tumor necrosis factor-related apoptosis-inducing ligand/Apo2L-induced apoptosis by suppressing nuclear factorkappaB via inhibition of the prosurvival Akt signaling pathway. J. Pharmacol. Exp. Ther. 321, 616-625 (2007).
33. Tanida, I., Ueno, T. & Kominami, E. LC3 conjugation system in mammalian autophagy. Int. J. Biochem. Cell Biol. 36, 2503-2518 (2004).
34. Klionsky, D. J. et al. Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy. 8, 445-544 (2012).
35. Maiuri, M. C. et al. Functional and physical interaction between Bcl-X(L) and a BH3-like domain in Beclin-1. EMBO J. 26, 2527-2539 (2007).
36. McKnight, N. C. et al. Beclin 1 Is Required for Neuron Viability and Regulates Endosome Pathways via the UVRAG-VPS34 Complex. PLoS Genet. 10, e1004626 (2014).
37. Tabas, I. & Ron, D. Integrating the mechanisms of apoptosis induced by endoplasmic reticulum stress. Nat. Cell. Biol. 13, 184-190 (2011).
38. Prevot, A. et al. Acute cyclosporine A-induced nephrotoxicity: a rabbit model. Pediatr. Nephrol. 14, 370-375 (2000).
39. Mimnaugh, E. G. et al. Simultaneous inhibition of hsp 90 and the proteasome promotes protein ubiquitination, causes endoplasmic reticulum-derived cytosolic vacuolization, and enhances antitumor activity. Mol. Cancer Ther. 3, 551-566 (2004).
40. Trachootham, D., Alexandre, J. & Huang, P. Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? Nat. Rev. Drug Discov. 8, 579-591 (2009).
41. Avivar-Valderas, A. et al. PERK integrates autophagy and oxidative stress responses to promote survival during extracellular matrix detachment. Mol. Cell. Biol. 31, 3616-3629 (2011).
42. Freedland, S. J. Screening, risk assessment, and the approach to therapy in patients with prostate cancer. Cancer. 117, 1123-1135 (2011).